Conclusions Rosiglitazone was associated with a significant increase in the risk of myocardial infarction and with an increase in the risk of death from cardiovascular causes that had borderline ...

New evidence reveals adult human hearts can regrow muscle cells after myocardial infarction, opening new possibilities for ...

Heart attacks, or acute myocardial infarction (MI), are one of the leading causes of death worldwide. The newly released Canadian Cardiovascular Society Classification of Acute Myocardial Infarction ...

A new study by investigators at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham (MGB) healthcare system, reveals an important step to help the human heart ...

New research discovers a potential path to prevent permanent scarring and heart failure following a myocardial infarction. A new study by investigators at Massachusetts General Hospital (MGH), a ...

Tirzepatide noninferior to dulaglutide with respect to composite of death from cardiovascular causes, myocardial infarction, or stroke.